Absolute lymphocyte count (ALC) ? /mm
Absolute lymphocyte count (ALC) </L.
Absolute lymphocyte count (ALC) >/L
Adequate organ function within  days of study registration including:\r\n* Absolute lymphocyte count (ALC) >= . x ^/L
Absolute lymphocyte count (ALC) >= / mm^
Absolute lymphocyte count (ALC) >=  cells/ul
PART I: Absolute lymphocyte count (ALC) >=  cells/mm^
PART II: ALC >=  cells/mm^
Absolute lymphocyte count (ALC) of > , K/uL
Absolute lymphocyte count (ALC) ? /mm^, and absolute number of CD+ T cells > /mm^
Absolute blood lymphocyte (ALC) >=  cells/ul\r\n* If subject has an apheresis product or T cells available for manufacturing of T cell product, there is no minimum ALC requirement
Absolute blood lymphocyte (ALC) >=  cells/ul\r\n* If subject has an apheresis product or T cells available for manufacturing of T cell product, there is no minimum ALC requirement
Absolute lymphocyte count (ALC) >= . x ^/L.
Absolute lymphocyte count (ALC) > cells/mm
Absolute lymphocyte count (ALC) >= /mm^
Patient must have no persistent toxicities from prior therapy >= grade  with the exception of\r\nhematologic indices (i.e., hemoglobin, white blood cell count [WBC], ANC, absolute lymphocyte count [ALC])
Absolute lymphocyte count (ALC) >= /uL
Absolute lymphocyte count (ALC) >=  cells/ul
Absolute lymphocyte count (ALC) > 
Patients must have absolute lymphocyte counts (ALC) of more than , cell/mm^
Absolute lymphocyte count (ALC) > /ul
Absolute lymphocyte count (ALC) >= /mm^
Absolute T-cell count (ATC) at screening >= . K/microL. This is defined as CD+ T-cell percent (expressed as fraction of %) multiplied by the absolute lymphocyte count (ALC, expressed in K/microL).
Absolute lymphocyte count (ALC) >= /uL
Absolute lymphocyte count (ALC) ? /mm
Progressive lymphocytosis in the absence of infection, with an increase in blood Absolute Lymphocyte Count (ALC) >=% over a -month period, or a lymphocyte doubling time (LDT) of < months (as long as initial ALC was >=/l).
either ALC > /L, or
Absolute lymphocyte count (ALC) ?   e/L
Patients with a diagnosis of CLL (any stage) with absolute lymphocyte count (ALC) >=  x /l, requiring therapy
Absolute lymphocyte count (ALC) >= /uL obtained =<  days prior to registration
For Phase b individuals: absolute lymphocyte count (ALC) > /?L in peripheral blood.
Absolute lymphocyte count (ALC) >= . X ^/L
Absolute lymphocyte count (ALC) >= /?L
ALC >/uL
Absolute lymphocyte count (ALC) ? ,/?l (? /?l after stem cell transplant) Note: After completion of dose escalation, patients with AML are not required to meet these hematologic criteria.
